Wolverine Asset Management LLC Mirum Pharmaceuticals, Inc. Put Options Transaction History
Wolverine Asset Management LLC
- $5.25 Billion
- Q2 2025
Put Options
2 transactions
Others Institutions Holding MIRM
# of Institutions
230Shares Held
56.1MCall Options Held
25.3KPut Options Held
98.9K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$493 Million18.24% of portfolio
-
Janus Henderson Group PLC London, X05.24MShares$380 Million0.14% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$235 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.76MShares$200 Million5.52% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$191 Million2.55% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $2.67B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...